Questioning the adequacy of standardized vitamin D supplementation protocol in very low birth weight infants: a

Hatice Sarıdemir1, Ozge Surmeli Onay1, Ozge Aydemir1

  • 1Department of Pediatrics, Division of Neonatology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.

Insights

A standardized vitamin D supplementation protocol effectively increased vitamin D levels in very low birth weight (VLBW) infants by 30 days. Maternal vitamin D status significantly correlated with infant levels, highlighting the importance of maternal vitamin D sufficiency.

Area of Science:

  • Neonatology
  • Nutritional Science
  • Pediatric Endocrinology

Background:

  • Preterm infants, particularly very low birth weight (VLBW) infants, exhibit a higher susceptibility to vitamin D deficiency (VDD).
  • Maternal vitamin D status is a critical determinant of neonatal vitamin D levels.
  • Optimal vitamin D levels are essential for infant growth and development, impacting bone health and immune function.

Purpose of the Study:

  • To evaluate the efficacy of a standardized vitamin D supplementation protocol in achieving adequate vitamin D levels in VLBW infants.
  • To investigate the relationship between maternal and infant vitamin D status at birth.
  • To explore potential associations between neonatal vitamin D status and infant morbidities.

Main Methods:

  • A single-center, prospective cohort study involving 55 mother-infant dyads.
  • Measurement of serum 25-hydroxyvitamin D (25OHD) levels in mothers before delivery and in infants at birth and 30 days of life (DOL).
  • Administration of vitamin D via parenteral nutrition (160 IU/kg/day) on DOL 1, followed by oral supplementation (400 IU/day) starting on DOL 15 or when enteral feedings reached 50%.

Main Results:

  • Infant 25OHD levels significantly increased from a median of 16.12 ng/mL at birth to 36.32 ng/mL by 30 DOL (p<0.01).
  • The supplementation protocol achieved sufficient 25OHD levels (>30 ng/mL) in 98% of VLBW infants by 30 DOL.
  • Maternal 25OHD levels were strongly correlated with cord blood 25OHD levels (r=0.665, p<0.001), and no maternal participants achieved sufficient levels.
  • Seasonal variations influenced cord blood 25OHD levels, with lower levels observed in winter.

Conclusions:

  • The current vitamin D supplementation protocol is effective in correcting vitamin D deficiency/insufficiency in VLBW infants by 30 DOL.
  • Maternal vitamin D status is a significant predictor of infant vitamin D levels at birth.
  • Further research may be warranted to optimize maternal vitamin D supplementation to improve neonatal stores and long-term outcomes.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
6.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
55
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
38
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
26
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
39
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
1.3K